IRVAN syndrome
Alternate names[edit | edit source]
Idiopathic retinal vasculitis-aneurysms-neuroretinitis syndrome; Idiopathic retinal-aneurysms-neuroretinitis syndrome
Definition[edit | edit source]
IRVAN syndrome is an acronym for "idiopathic retinal vasculitis-aneurysms-neuroretinitis syndrome," a condition that primarily affects the eyes.
Cause[edit | edit source]
The underlying cause of IRVAN syndrome is currently unknown.
Inheritance[edit | edit source]
Most cases occur sporadically in people with no family history of the condition.
Onset[edit | edit source]
Although this condition can occur in people of all ages, it is most commonly diagnosed in the third or fourth decade of life.
Signs and symptoms[edit | edit source]
The severity of the condition varies from person to person with some affected people experiencing a mild form that resolves on its own and others experiencing a severe form that may progress to vitreous hemorrhage (leakage of blood into the eye), vision loss and/or glaucoma.
Clinical presentation[edit | edit source]
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
30%-79% of people have these symptoms
- Ocular hypertension(High eye pressure)
- Reduced visual acuity(Decreased clarity of vision)
- Vitreous floaters(Eye floaters)
5%-29% of people have these symptoms
- Blurred vision
- Glaucoma
- Macular edema
- Optic atrophy
- Photophobia(Extreme sensitivity of the eyes to light)
- Retinal exudate
- Tractional retinal detachment
Diagnosis[edit | edit source]
The disease has variable clinical presentation, and clinical diagnosis is aided by the help of ophthalmic imaging, such as fundus fluorescein angiography (FFA), preferably by wide-field system and optical coherence tomography (OCT).[1].
Treatment[edit | edit source]
- Treatment varies based on the severity of the condition and the associated signs and symptoms.
- In severe cases, surgery or medications such as corticosteroids may be recommended.
- Early intervention in these patients in the form of prompt laser treatment without waiting for neovascularization to develop is important.
- Anti-VEGF and infliximab have been used as adjunctive treatment in IRVAN with laser treatment to reduce disease progression. [2].
References[edit | edit source]
- ↑ Bajgai, P., Katoch, D., Dogra, M. R., & Singh, R. (2017). Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clinical ophthalmology (Auckland, N.Z.), 11, 1805–1817. https://doi.org/10.2147/OPTH.S128506
- ↑ Bajgai, P., Katoch, D., Dogra, M. R., & Singh, R. (2017). Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clinical ophthalmology (Auckland, N.Z.), 11, 1805–1817. https://doi.org/10.2147/OPTH.S128506
NIH genetic and rare disease info[edit source]
IRVAN syndrome is a rare disease.
This article is a stub. You can help WikiMD by registering to expand it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju